Back to Search
Start Over
Supplementary Figures + Legend from Optimized Doxorubicin Chemotherapy for Diffuse Large B-cell Lymphoma Exploits Nanocarrier Delivery to Transferrin Receptors
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplemental Figures 1-9. Figure S1. Carbon-Nitride Dot Synthesis. Figure S2. Characterization of CND-Dox-TF. Figure S3. CND cytotoxicity. Figure S4. Cell surface TFR1 expression and receptor recycling. Figure S5. Rapid nuclear entry by Dox after CND-Dox-TF treatment in DLBCL. Figure S6. HEK293 is a model cell line for elucidating CND-Dox-TF mechanism. Figure S7. CND-Dox-TF working dose identified. Figure S8. CND-Dox-TF has improved toxicity profile compared to Dox. Figure S9. R-nanoCHOP treatment has favorable toxicity profile in non-malignant organs.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....1092ecf2ba54526775f4544f52e93b20